title: Rituximab is effective in the treatment of patients with idiopathic inflammatory myopathy.
authors.forename: F J
authors.initials: FJ
authors.lastname: Garcia-Hernandez
authors.forename: R
authors.initials: R
authors.lastname: Gonzalez-Leon
authors.forename: M J
authors.initials: MJ
authors.lastname: Castillo-Palma
authors.forename: J
authors.initials: J
authors.lastname: Sanchez-Roman
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D018501:Antirheumatic Agents / Q000008:administration & dosage; D009220:Myositis / Q000188:drug therapy; D000069283:Rituximab; D016896:Treatment Outcome; D002986:Clinical Trials as Topic
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D000069283:Rituximab